4.7 Article

Vaccine-Induced Subcutaneous Granulomas in Goats Reflect Differences in Host-Mycobacterium Interactions between BCG- and Recombinant BCG-Derivative Vaccines

Related references

Note: Only part of the references are listed.
Review Microbiology

The Bovine Tuberculoid Granuloma

Mitchell V. Palmer et al.

Summary: The bovine tuberculoid granuloma is a characteristic lesion of bovine tuberculosis, playing a key role in controlling the disease. However, it may also provide a niche for bacterial replication. Understanding the mechanisms behind granuloma formation and maintenance is crucial for assessing disease severity and vaccine efficacy.

PATHOGENS (2022)

Article Infectious Diseases

The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB

Jeremiah Chakaya et al.

Summary: The 2021 WHO global TB report presents a grim situation in the global epidemic of TB, including a stagnation in TB incidence decline, a decline in TB notifications, and an increase in estimated TB deaths. None of the targets set at the 2018 United Nations High Level Meeting on TB were achieved. The sub-optimal global performance in achieving TB control targets in 2020 is attributed to the COVID-19 pandemic, but TB programs were already off track before the pandemic, highlighting the fragility of the global TB response. Ending the global TB epidemic requires bold leadership, optimization of interventions, widespread coverage, addressing social determinants, and mobilization of adequate funding.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Review Infectious Diseases

100 years of Mycobacterium bovis bacille Calmette-Guerin

Christoph Lange et al.

Summary: The BCG vaccine, initially designed for cattle, has saved many lives since its first administration to a newborn in Paris in 1921. While providing strong protection against miliary and meningeal tuberculosis in children, it is less effective in preventing pulmonary tuberculosis in adults. It has also shown non-specific benefits against non-tuberculous infections and immunotherapeutic benefits in certain cancers.

LANCET INFECTIOUS DISEASES (2022)

Review Infectious Diseases

Accelerating research and development of new vaccines against tuberculosis: a global roadmap

Frank Cobelens et al.

Summary: In order to eliminate tuberculosis worldwide, there is an urgent need for a new, effective, and affordable vaccine, especially for adults and adolescents in low-income and middle-income countries. A roadmap has been created to accelerate tuberculosis vaccine research and development through a participatory process. The vaccine pipeline needs to incorporate more diverse immunological approaches, antigens, and platforms. Clinical development can be expedited through validated preclinical models, agreed laboratory correlates of protection, efficient trial designs, and validated endpoints. The public health impact of new tuberculosis vaccines can be determined by understanding the demand for them in each country, integrating vaccine implementation with ongoing tuberculosis prevention efforts, considering cost, and stimulating vaccine production on a national and global scale. Investments in tuberculosis vaccine research and development should be increased, with diversification of funding sources and coordination between funders. Open science is crucial for enhancing the efficiency of tuberculosis vaccine research and development, including early and freely available publication of study findings, as well as effective mechanisms for sharing datasets and specimens. Increased engagement of industry vaccine developers, political commitment to new tuberculosis vaccines, and addressing stigma and vaccine hesitancy are also necessary. The rapid development and introduction of COVID-19 vaccines provide valuable insights for tuberculosis vaccine research and development.

LANCET INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial

Mark F. Cotton et al.

Summary: This study compared the safety and immunogenicity of VPM1002 and BCG in HIV exposed and unexposed newborn babies, showing that VPM1002 was less reactogenic than BCG, with differences in immunogenic responses.

LANCET INFECTIOUS DISEASES (2022)

Review Fisheries

Goat γδ T cells

Alehegne Yirsaw et al.

Summary: Goats are significant food animals with high adaptability. Infectious diseases can impact their productivity, while gamma delta T cells play important roles in immune responses. These cells respond to various infections and may have altered representation and function due to infection.

DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2021)

Review Microbiology

Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success

Stefan H. E. Kaufmann

Summary: The year 2020 was marked by the COVID-19 pandemic, but also brought hope with the development of vaccines. While the BCG vaccine has saved millions of lives, current vaccines are still insufficient. Recent advancements in novel vaccine development show promise, but the effectiveness of controlling tuberculosis remains uncertain.

FRONTIERS IN MICROBIOLOGY (2021)

Review Cell Biology

Breaching the phagosome, the case of the tuberculosis agent

Roxane Simeone et al.

Summary: This passage discusses the complex interactions between microbes and hosts, highlighting both beneficial interactions and defense strategies against virulent pathogens. It specifically mentions the key role of confining invading pathogens in a phagosome for the destruction of the invader.

CELLULAR MICROBIOLOGY (2021)

Review Biochemistry & Molecular Biology

Neutrophils in Tuberculosis: Cell Biology, Cellular Networking and Multitasking in Host Defense

Rachana R. Borkute et al.

Summary: Neutrophils play a complex role in tuberculosis, with both beneficial and detrimental effects on disease outcomes. Recent studies have revealed the phenotypic heterogeneity of neutrophils and their interactions with other cells in TB pathophysiology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Microbiology

Macrophage-specific responses to human- and animal-adapted tubercle bacilli reveal pathogen and host factors driving multinucleated cell formation

Christophe J. Queval et al.

Summary: The study revealed that Mbv and Mtb exhibit different behaviors in host cells, with Mbv infection leading to multinucleated cell formation in bovine macrophages. It was identified that MPB70 from Mbv and bovine macrophage extracellular vesicles are mechanistic drivers of multinucleated cell formation. In vivo confirmation of differential multinucleated cell formation in cattle models further supports the role of these factors in host tropism in human/bovine tuberculosis.

PLOS PATHOGENS (2021)

Article Veterinary Sciences

Heterogeneity of Pulmonary Granulomas in Cattle Experimentally Infected With Mycobacterium bovis

Mitchell V. Palmer et al.

Summary: The study found that bacterial burdens within individual granulomas examined 30 days after infection were greater and more heterogenous compared to those examined 90 to 270 days after infection. Granuloma stage had modest positive and negative correlations with TNF-alpha and IL-10, respectively. However, heterogeneity and mean expression of IFN-gamma, IL-10 and TNF-alpha did not differ significantly over time.

FRONTIERS IN VETERINARY SCIENCE (2021)

Article Pathology

Morphology of Naturally-Occurring Tuberculosis in Cattle Caused by Mycobacterium caprae

H. Ozturk-Gurgen et al.

JOURNAL OF COMPARATIVE PATHOLOGY (2020)

Review Pathology

Microbial Offense vs Host Defense: Who Controls the TB Granuloma?

Amanda J. Martinot

VETERINARY PATHOLOGY (2018)

Review Infectious Diseases

Experimental animal modelling for TB vaccine development

Pere-Joan Cardona et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)

Review Microbiology

The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis

Christophe J. Queval et al.

FRONTIERS IN MICROBIOLOGY (2017)

Review Immunology

The Recombinant Bacille Calmette-Guerin Vaccine VPM1002: Ready for Clinical Efficacy Testing

Natalie E. Nieuwenhuizen et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells

Kourosh Gharun et al.

EMBO REPORTS (2017)

Article Cardiac & Cardiovascular Systems

Chest wall granuloma associated with BCG vaccination presenting as hot abscess in an immunocompetent infant

Hyun Seung Lee et al.

JOURNAL OF CARDIOTHORACIC SURGERY (2015)

Article Immunology

Development of an in vitro model of the early-stage bovine tuberculous granuloma using Mycobacterium bovis-BCG

Laura Garza-Cuartero et al.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2015)

Article Veterinary Sciences

Tuberculosis in domestic animal species

M. Pesciaroli et al.

RESEARCH IN VETERINARY SCIENCE (2014)

Article Veterinary Sciences

Pathology of bovine tuberculosis

M. Domingo et al.

RESEARCH IN VETERINARY SCIENCE (2014)

Review Immunology

The granuloma in tuberculosis: dynamics of a host-pathogen collusion

Stefan Ehlers et al.

FRONTIERS IN IMMUNOLOGY (2013)

Review Pathology

Tuberculosis Pathogenesis and Immunity

Jennifer A. Philips et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)

Review Immunology

The Tuberculous Granuloma: An Unsuccessful Host Defence Mechanism Providing a Safety Shelter for the Bacteria?

Mayra Silva Miranda et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Review Immunology

Revisiting the role of the granuloma in tuberculosis

Lalita Ramakrishnan

NATURE REVIEWS IMMUNOLOGY (2012)

Review Immunology

Macrophages and control of granulomatous inflammation in tuberculosis

J. L. Flynn et al.

MUCOSAL IMMUNOLOGY (2011)

Article Medicine, Research & Experimental

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism

Mi-Jeong Kim et al.

EMBO MOLECULAR MEDICINE (2010)

Review Immunology

Foamy macrophages and the progression of the human tuberculosis granuloma

David G. Russell et al.

NATURE IMMUNOLOGY (2009)

Article Immunology

Innate immunity in tuberculosis: myths and truth

Daniel S. Korbel et al.

MICROBES AND INFECTION (2008)

Article Microbiology

Location of persisting mycobacteria in a guinea pig model of tuberculosis revealed by R207910

Anne J. Lenaerts et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)

Article Biochemistry & Molecular Biology

M-tuberculosis and M-leprae translocate from the phagolysosome to the cytosol in myeloid cells

Nicole van der Wel et al.

Review Oncology

New insights into the function of granulomas in human tuberculosis

T Ulrichs et al.

JOURNAL OF PATHOLOGY (2006)

Article Immunology

Interaction of antigen presenting cells with mycobacteria

JC Hope et al.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2004)

Article Biochemistry & Molecular Biology

Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis

UE Schaible et al.

NATURE MEDICINE (2003)